Europe looks like one large healthcare market from a distance.

But founders do not sell into Europe as one market.

They sell into individual countries, regions, hospital groups, payer structures, procurement bodies, and public health systems.

That changes everything.

This week’s HealthVC newsletter breaks down why fragmentation is one of the biggest barriers to building global healthtech companies from Europe.